Signaturefd LLC Buys 104 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Signaturefd LLC raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 759 shares of the biotechnology company’s stock after purchasing an additional 104 shares during the period. Signaturefd LLC’s holdings in Axon Enterprise were worth $451,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Parallel Advisors LLC grew its stake in shares of Axon Enterprise by 8.8% during the 4th quarter. Parallel Advisors LLC now owns 962 shares of the biotechnology company’s stock valued at $572,000 after acquiring an additional 78 shares during the period. Cibc World Markets Corp lifted its holdings in Axon Enterprise by 35.1% during the fourth quarter. Cibc World Markets Corp now owns 13,118 shares of the biotechnology company’s stock valued at $7,796,000 after purchasing an additional 3,406 shares in the last quarter. Corient Private Wealth LLC boosted its position in shares of Axon Enterprise by 16.3% in the fourth quarter. Corient Private Wealth LLC now owns 8,182 shares of the biotechnology company’s stock worth $4,863,000 after purchasing an additional 1,146 shares during the period. Envestnet Portfolio Solutions Inc. increased its stake in shares of Axon Enterprise by 0.8% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 4,900 shares of the biotechnology company’s stock worth $2,912,000 after purchasing an additional 41 shares in the last quarter. Finally, Natixis Advisors LLC raised its position in shares of Axon Enterprise by 2.8% during the 4th quarter. Natixis Advisors LLC now owns 31,251 shares of the biotechnology company’s stock valued at $18,573,000 after purchasing an additional 859 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

AXON has been the subject of several recent analyst reports. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $558.41 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The stock’s 50 day simple moving average is $592.10 and its two-hundred day simple moving average is $539.60. The company has a market cap of $42.79 billion, a price-to-earnings ratio of 144.29, a PEG ratio of 5.17 and a beta of 1.12.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. The trade was a 0.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,792 shares of company stock valued at $1,087,843 in the last quarter. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.